Detect Lung Cancer Earlier with Nasal Swabs
Fast. Accurate. Needle-Free
Built for Comfort. Backed by Data. Designed for Impact.
Non-Invasive & Comfortable
Eliminates the need for biopsies, needles, or radiation by using a simple nasal swab. Designed for patient comfort, built for clinical accuracy.
Active Clinical
Validation
Currently being validated in a multi-center studies across 10+ hospitals in Europe and the US.
High Diagnostic
Yield
Nasal samples offer a richer source of diagnostic DNA than blood, supporting higher sensitivity and more confident clinical decisions.
Designed for
Expansion
Initially developed for lung cancer, OncoSwab is built to extend into upper-airway cancers and other respiratory diseases.
How Our Technology Works
Healthcare provider collects nasal fluids using our specialized swab kit. Our lab analyzes cellular markers associated with lung cancer development. Machine learning algorithms provide accurate risk assessment and recommendations. Our technology offers a more accessible and precise way to assess nodule malignancy risk, helping clinicians make informed decisions sooner and reducing the need for invasive follow-ups.
Transform Lung Cancer Detection
Earlier detection increases treatment success rates by up to 90%
Non-invasive testing improves patient comfort and compliance
Rapid results enable faster clinical decision-making
Cost-effective detection for high-risk populations
AI-powered analysis ensures consistent accuracy
Be Part of the Solution
& Individuals
Providers
& Partners
& Industry
.png){kind=logo}
.png)